BDX vs SCL · P/E 34, rev $21.84B vs P/E 22, rev $2.18B
Becton Dickinson and Company (BDX) versus Stepan Company (SCL) — a side-by-side from cached financials, not a winner call.
Becton Dickinson and Company (BDX) is a medical instruments & supplies company listed on US.
Stepan Company (SCL) is a specialty chemicals company listed on US.
Latest reported BDX revenue for 2025-09-30 was $21.84B. Net income was $1.68B. Revenue was up 8.2% from 2024-09-30 to 2025-09-30. BDX currently screens at market cap $50.30B and trailing P/E 33.9.
Latest reported SCL revenue for 2024-12-31 was $2.18B. Net income was $50.4M. Revenue was down 6.3% from 2023-12-31 to 2024-12-31. SCL currently screens at market cap $1.29B and trailing P/E 22.3.
BDX currently screens at market cap $50.30B and trailing P/E 33.9. SCL currently screens at market cap $1.29B and trailing P/E 22.3.
Not investment advice. Open the BDX and SCL stock pages for the full models.
Not investment advice.